Correction: Cocaine enhances HIV-1 replication in CD4+T cells by down-regulating MiR-125b (PLoS ONE (2012) 7: 12 (e51387) DOI: 10.1371/journal.pone.0051387);Cocaine Enhances HIV-1 Replication in CD4+ T Cells by Down-Regulating MiR-125b

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Mantri, Chinmay K ^a   Pandhare Dash, Jui ^a   Mantri, Jyoti Velamarti ^a   Dash, Chandravanu C V ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; MICRORNA; MICRORNA 125B; MICRORNA 150; MICRORNA 223; MICRORNA 28; MICRORNA 382; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS RNA;

3' UNTRANSLATED REGION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE COURSE; DRUG TARGETING; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; VIRUS ENTRY; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 84871199350     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0199338     Document Type: Erratum

References (44)

1. Goedert JJ, (1984) Recreational drugs: relationship to AIDS. Ann N Y Acad Sci. 437: 192-199.
2. Siegel L, (1986) AIDS: relationship to alcohol and other drugs. J Subst Abuse Treat 3: 271-274.
3. Donahoe RM, Falek A, (1988) Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. Adv Biochem Psychopharmacol 44: 145-158.
4. Friedman H, (1996) Drugs of abuse as possible co-factors in AIDS progression: summary of panel discussion. Adv Exp Med Biol 402: 225-228.
5. Cabral GA, (2006) Drugs of Abuse, Immune Modulation, and AIDS. J Neuroimmune Pharmacol 1: 280-295.
6. Khalsa JH, Royal W, (2004) Do drugs of abuse impact on HIV disease. J. Neuroimmunol. 147: 6-8.
7. Friedman H, Pross S, Klein TW, (2006) Addictive drugs and their relationship with infectious diseases. FEMS Immunol Med Microbiol 47: 330-342.
8. Kopnisky KL, Bao J, Lin YW, (2007) Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report. Brain Behav Immun 21: 428-441.
9. Chaisson RW, Bacchetti P, Osmond D, Brodie B, Sande MA, et al. (1989) Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261: 561-565.
10. Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, et al. (1991) New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol 134: 1175-1189.
11. Baum MK, Rafie C, Lai S, Sales S, Page B, et al. (2009) Crack-Cocaine Use Accelerates HIV Disease Progression in a Cohort of HIV-Positive Drug Users. J Acquir Immune Defic Syndr 50: 93-99.
12. Duncan R, Shapshak P, Page JB, Chiappelli F, McCoy CB, et al. (2007) Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women. Front Biosci 12: 488-495.
13. Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, et al. (2008) Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 22: 1355-1363.
14. Peterson PK, Gekker G, Chao CC, Schut R, Molitor TW, et al. (1991) Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell co-cultures. Involvement of transforming growth factor-beta. J Immunol 146: 81-84.
15. Bagasra O, Pomerantz RJ, (1993) Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis 168: 1157-1164.
16. Roth MD, Tashkin DP, Choi R, Jamieson BD, Zack JA, et al. (2002) Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis 2002 185: 701-705.
17. Rofael HZ, Turkall RM, Abdel-Rahman MS, (2003) Immunomodulation by cocaine and ketamine in postnatal rats. Toxicology 188: 101-14.
18. Watzl B, Watson RR, (1990) Immunomodulation by cocaine-a neuroendocrine mediated response. Life Sci 46: 1319-29.
19. Halpern JH, Sholar MB, Glowacki J, Mello NK, Mendelson JH, et al. (2003) Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration. J Clin Endocrinol Metab 88(3): 1188-1193.
20. Nair MP, Mahajan S, Chadha KC, Nair NM, Hewitt RG, et al. (2001) Effect of cocaine on chemokine and CCR-5 gene expression by mononuclear cells from normal donors and HIV-1 infected patients. Adv Exp Med Biol 493: 235-40.
21. Nair MP, Chadha KC, Hewitt RG, Mahajan S, Sweet A, et al. (2000) Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol 7(1): 96-100.
22. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo SK, et al. (1995) Identification of RANTES, MIP-1a MIP-1b as the major HIV suppressive factors produced by CD81 T cells. Science 270: 1811-1815.
23. Reynolds JL, Mahajan SD, Aalinkee lR, Nair B, Sykes DE, et al. (2009) Modulation of the Proteome of Peripheral Blood Mononuclear Cells from HIV-1-Infected Patients by Drugs of Abuse. J Clin Immunol 29: 646-656.
24. Telesnitsky A, Goff SP (1997) Reverse Transcriptase and the Generation of Retroviral DNA: In Coffin JM, Hughes SH, Varmus HEeditors. Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, New York, 121-160.
25. Bartel DP, (2004) MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell 116(2): 281-297.
26. Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S (2012): MiR-125 in normal and malignant hematopoiesis. Leukemia. doi: 10.1038/leu.2012.90. [Epub ahead of print].
27. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. (2002) Curr Biol. 12: 735-739.
28. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, et al. (2011) Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4(+) T cells by the microRNA miR-125b. Nat Immunol 12(8): 796-803.
29. Huang J, Wang F, Argyris E, Chen K, Liang Z, et al. (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 13: 1241-1247.
30. Wang X, Ye L, Hou W, Zhou Y, Wang YJ, et al. (2009) Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113: 671-674.
31. Witwer KW, Watson AK, Blankson JN, Clements JE, (2012) Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 9: 5.
32. Chiang K, Rice AP, (2011) Mini ways to stop a virus: microRNAs and HIV-1 replication Future Virol. 6: 209-221.
33. Hariharan M, Scaria V, Pillai B, Brahmachari SK, (2005) Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 337: 1214-1218.
34. Clouse KA, Powell D, Washington I, Poli G, Strebel K, et al. (1989) Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 142: 431-438.
35. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, et al. (1989) Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A 86: 2365-2368.
36. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, et al. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46: 1896-1905.
37. Stephens BG, Jentzen JM, Karch S, Mash DC, Wetli CV, (2004) Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death. Am J Forensic Med Pathol 25: 1-10.
38. Van Dyke C, Barash PG, Jatlow P, Byck R, (1976) Cocaine: plasma concentrations after intranasal application in man. Science 191: 859-861.
39. Broder CC, Collman RG, (1997) Chemokine receptors and HIV. J Leukoc Biol 62: 20-29.
40. Chan D, Kim P, (1998) HIV entry and its inhibition. Cell 93: 681-684.
41. Wyatt R, Sodroski J, (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280: 1884-1888.
42. Aiken C, (1997) Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J Virol. 71: 5871-5877.
43. Morey JS, Ryan JC, Van Dolah FM, (2006) Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online 8: 175-193.
44. Wang X, Ye L, Zhou Y, Liu MQ, Zhou DJ, Ho WZ, (2011) Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am J Pathol. 178: 41-47.